Early Screening and Identification for Panvascular Diseases

Beijing Tiantan Hospital1,000 enrolled

Overview

Identify the pathogenic factors involved in the occurrence and development of panvascular disease and its pathogenesis.

Identify the pathogenic factors involved in the occurrence and development of panvascular disease and its pathogenesis by a multi-omics study.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Panvascular Diseases

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * 1\. Patients with panvascular diseases; 2. Patients or guardians who agreed to join the study; 3. Patients who can complete the relevant examinations involved in this study; Exclusion Criteria: * patients with coagulation dysfunction.

Locations (1)

Beijing Tiantan Hospital Capital Medical University

Beijing, Beijing Municipality, China

RECRUITING

Outcomes

Primary Outcomes

Any new stroke events

Incidence of any new ischemic or hemorrhagic stroke

Time frame: Up to 48 months

Central Contacts

Peicong Ge, MD

CONTACT

15010545727 gepeicong@163.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.